Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.32 -2.11%
EPS Growth %: +400.0%
Financial Fact:
REVENUES: 4.67M
Today's EPS Names:
LRHC, COHN, ECHO, More
EPS Growth %: +400.0%
Financial Fact:
REVENUES: 4.67M
Today's EPS Names:
LRHC, COHN, ECHO, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.16). Revenue for the quarter came in at $24.84 million versus the consensus estimate of $10.22 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allison Transmission (ALSN) Tops Q2 EPS by 33c; offers guidance
- ONEOK (OKE) Tops Q2 EPS by 4c; offers guidance
- Paymentus Holdings Inc. (PAY) Tops Q2 EPS by 7c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
